铁死亡调控通路及其在肿瘤放化疗和免疫治疗抵抗中的研究进展

doi:10.3969/j.issn.1674-5671.2022.06.15

Wechat

Website

Chinese Journal of Oncology Prevention and Treatment ›› 2022, Vol. 14 ›› Issue (6): 682-686.doi: 10.3969/j.issn.1674-5671.2022.06.15

Previous Articles Next Articles

Advances in the regulatory pathway of ferroptosis and its research in tumor radiotherapy and immunotherapy resistance

Online:2022-12-25 Published:2022-12-30

Abstract

CLC Number:

R730.2

WANG Tingan, WU Liucheng, WEI Weiyuan, LING Tong, HUANG Mingwei, QIN Yuzhou. Advances in the regulatory pathway of ferroptosis and its research in tumor radiotherapy and immunotherapy resistance[J].Chinese Journal of Oncology Prevention and Treatment, 2022, 14(6): 682-686.

[1]	LI Bingbing, XU Ke . Role of m7G methyltransferase METTL1 in tumor and its mechanism [J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 747-752.
[2]	DI Yingjie, XUE Yaoqin, REN Jinrui, OU Aixin, LIU Yue . Research progress on the mechanism of Pirfenidone anti-tumor action [J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 494-498.
[3]	AN Pingping, FAN Ruyu, ZHOU Shijin, YE Xuanxuan, WU Cong . Research progress on the mechanisms of Per gene in tumors [J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 354-360.
[4]	ZHANG Jiayuan, LIU Li, ZHOU Yuqiu. Research progress on help-seeking behaviour for cancer symptoms of cancer patients [J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 380-384.
[5]	XIAN Shinan, MO Yingxi, WANG Shan, YANG Yiping, ZHANG Qingyun. Role of protein phosphatase 4 catalytic subunit in tumor progression [J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 249-254.
[6]	LIAN Jiawei, LIU Yingchun, YU Hongping. Colorectal cancer：global epidemiology,risk factors and advances in attributed disease burden [J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 1-9.
[7]	GE Shengyang, LI Wei, YU Wenqiang. Inventory of tumor methylation marker research progress in 2023 [J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 10-16.
[8]	LYU Yizhen, SUN Shiquan. Inventory of advances in single⁃cell and spatial multi⁃omics of tumors in 2023 [J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 17-22.
[9]	ZHOU Xinmeng, LIAO Qingqing, XIE Na, HUANG Canhua, SUN Xiaodong, ZHANG Yuanyuan. Inventory of tumor protein marker research progress in 2023 [J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 23-31.
[10]	XI Wenwen, LYU Bin . Inventory of mitochondrial tumor markers research progress in 2023 [J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 32-37.
[11]	CHEN Yao, LI Li, MIAO Hongming, YANG Fan. Inventory of tumor metabolic markers research progress in 2023 [J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 38-42.
[12]	XIE Li, SONG Xianrang. Inventory of liquid biopsy marker research progress in 2023 [J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 43-49.
[13]	TANG Shaomei, YU Hongping, WEI Qingyi. DNA mismatch repair gene variants/mutations and cancer treatment response [J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 593-601.
[14]	DUAN Haibo, LIU Yuhang, WANG Xiongjun. Multifaceted hand of tumor stress : glutamate dehydrogenase 1 (GLUD1) [J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 602-609.
[15]	YE Yiyi. Heterogeneity of neutrophils and tumor [J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 677-683.

Advances in the regulatory pathway of ferroptosis and its research in tumor radiotherapy and immunotherapy resistance

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0